Quotes Oramed Pharmaceuticals Inc. Deutsche Boerse AG
Stocks
OJU1
US68403P2039
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
03:01:27 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 4.128 EUR | +1.18% |
|
-0.25% | +68.74% |
| 09-20 | Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to S&P Global BMI Index | CI |
| 08-31 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
Stock exchange
Deutsche Boerse AG
OJU1 4.070 €
-0.25%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ORMP | 4.670USD | -0.43% | 603K $ | ||
CBOE
| ORMP | 4.670USD | -0.43% | 15.53K $ | |
|
TEL AVIV STOCK EXCHANGE
| ORMP | 1,419.00ILa | -1.80% | 2.59M ILa | |
|
Deutsche Boerse AG
| OJU1 | 4.070EUR | -0.25% | 0 € | |
|
Tradegate
| OJU1 | 4.120EUR | -0.48% | 0 € | |
|
Börse Stuttgart
| OJU1 | 4.095EUR | +0.12% | 0 € | |
|
Boerse Muenchen
| OJU1 | 4.145EUR | 0.00% | 0 € |
Quotes 5-day view: Oramed Pharmaceuticals Inc.
Delayed Quote Deutsche Boerse AG
| 2026-09-25 | 2026-09-28 | 2026-09-29 | 2026-09-30 | 2026-10-01 | |
|---|---|---|---|---|---|
| Last | €4.150 | €4.100 | €4.120 | €4.080 | €4.070 |
| Volume | 0 | 0 | 30 | 0 | 0 |
| Change | +1.72% | -1.20% | +0.49% | -0.97% | +1.18% |
| Opening | €4.150 | €4.100 | €4.120 | €4.080 | €4.070 |
| High | €4.150 | €4.100 | €4.120 | €4.080 | €4.070 |
| Low | €4.150 | €4.100 | €4.120 | €4.080 | €4.070 |
Performance
| 1 day | +1.18% | ||
| 1 week | -0.25% | ||
| Current month | -0.25% | ||
| 1 month | -4.35% | ||
| 3 months | -2.05% | ||
| 6 months | +40.20% | ||
| Current year | +68.74% | ||
| 1 year | +84.41% | ||
| 3 years | +62.22% | ||
| 5 years | -77.08% | ||
| 10 years | -36.11% |
Volumes
marketsDaily volume
0
Estimated daily volume
0
Avg. Volume 20 sessions
139
Daily volume ratio
0
Avg. Volume 20 sessions
573.79
Avg. Volume 20 sessions USD
648.99
Record volume 1
98,495
Record volume 2
60,675
Record volume 3
58,541
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
194,259,643
Market Cap (USD)
194,259,643
Net sales (USD)
2,000,000
Number of employees
4
Sales / Employee (USD)
500,000
Free-Float
78.61%
Free-Float capitalization (EUR)
173,410,575
Free-Float capitalization (USD)
152,705,353
Average Daily Capital Traded
-.--%
Indicators
Moving average 5 days
4.106
Moving average 20 days
4.109
Moving average 50 days
3.948
Moving average 100 days
3.765
Price spread / (MMA5)
-0.53%
Price spread / (MMA20)
-0.47%
Price spread / (MMA50)
-4.37%
Price spread / (MMA100)
-8.79%
RSI 9 days
53.79
RSI 14 days
53.6
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.18% | -0.25% | +84.41% | +62.22% | 194M | |
| +4.16% | -0.36% | +49.37% | +94.17% | 74.46B | |
| -0.05% | +1.70% | +28.36% | +81.80% | 60.14B | |
| -0.52% | +2.39% | +9.10% | +35.15% | 48.15B | |
| -0.05% | +0.37% | +41.54% | +36.65% | 44.25B | |
| +0.38% | +7.61% | +339.53% | +641.55% | 43.99B | |
| +0.18% | +0.26% | +7.41% | +103.45% | 41.61B | |
| -0.67% | +0.17% | +7.60% | +46.37% | 29.97B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 29.31B | |
| -1.29% | -3.55% | -20.74% | +352.04% | 24.93B | |
| Average | +0.82% | +1.53% | +58.34% | +147.62% | 39.7B | |
| Weighted average by Cap. | +1.00% | +1.53% | +59.72% | +147.65% |
Historical Quotes: Oramed Pharmaceuticals Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 4.07 |  | 4.15 |
| 1 month | 3.94 | | 4.3 |
| Current year | 2.4 | | 4.53 |
| 1 year | 1.88 | | 4.53 |
| 3 years | 1.6 | | 4.53 |
| 5 years | 1.6 | | 26.25 |
| 10 years | 1.6 | | 26.25 |
Monthly variations
Annual variations
| 2026 | +69.15% | ||
| 2025 | +6.87% | ||
| 2024 | +7.94% | ||
| 2023 | -81.46% | ||
| 2022 | 0.00% | ||
| 2021 | +219.09% | ||
| 2020 | -22.14% | ||
| 2019 | +71.97% | ||
| 2018 | -65.36% | ||
| 2017 | +30.50% | ||
| 2016 | -27.30% | ||
| 2015 | +125.71% | ||
| 2014 | +26.21% | ||
| 2012 | +47.80% | ||
| 2011 | -33.19% | ||
| 2010 | -14.08% | ||
| 2009 | +13.99% | ||
| 2008 | +62.00% | ||
| 2007 | -73.21% | ||
| 2006 | -28.21% |
- Stock Market
- Stocks
- ORMP Stock
- OJU1 Stock
- Quotes Oramed Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
